Press & Media Center
Expert sources for journalists · HARO responses · Data & statistics · Interview requests
📰 Media Inquiries
BiologicHealthPlus clinical pharmacists are available as expert sources on biologic medications, specialty pharmacy, insurance, biosimilars, and patient access to specialty drugs.
About BiologicHealthPlus
BiologicHealthPlus is an NABP-accredited specialty pharmacy exclusively focused on biologic and specialty medications for autoimmune, inflammatory, and metabolic conditions. We serve patients in all 50 US states and provide comprehensive support services — prior authorization, copay enrollment, and free cold-chain delivery — at no charge to patients.
24+
FDA-approved biologics dispensed
50
US states served
16+
Autoimmune conditions covered
24/7
Pharmacist availability
$0
Cost for all PA & insurance services
Expert Topics for Media Coverage
BiologicHealthPlus pharmacists are available to comment on the following topics for news articles, features, podcasts, and broadcast segments:
💊 Biologic Medications
- Biologic vs biosimilar costs and access
- How biologics treat autoimmune disease
- Comparing biologic mechanisms of action
- Biologic adherence and persistence
- Side effects and safety monitoring
💰 Drug Pricing & Access
- Why biologic medications cost so much
- PBM rebate walls and biosimilar access
- Patient assistance programs explained
- Copay card programs — how they work
- Medicare drug pricing and biologics
🏥 Specialty Pharmacy
- What specialty pharmacies do differently
- Prior authorization — the patient burden
- Cold-chain medication delivery
- Specialty pharmacy accreditation (NABP)
- Pharmacist role in patient outcomes
🧬 Biosimilar Market
- Post-Humira biosimilar competition
- FDA interchangeable biosimilar policy
- Biosimilar adoption challenges
- Upcoming biologic patent expirations
- Patient concerns about switching
🤝 Patient Advocacy
- Step therapy reform and patient rights
- Insurance denial and appeals process
- Medication adherence and outcomes
- GLP-1 coverage challenges
- Autoimmune patient perspectives
📊 Data & Statistics
- Biologic medication market data
- Patient cost and savings statistics
- Prior authorization approval rates
- Specialty pharmacy industry trends
- Autoimmune disease prevalence data
Key Statistics & Data Points
| Statistic | Figure | Source |
|---|---|---|
| Americans with autoimmune conditions | ~50 million | AARDA |
| Annual Humira (adalimumab) list price (pre-biosimilar) | ~$84,000–$96,000 | WAC pricing |
| Average biologic copay with manufacturer program | $0–$35/month | Manufacturer savings programs |
| FDA-approved adalimumab (Humira) biosimilars | 8+ | FDA, 2026 |
| Prior authorization denial rate (biologics) | Up to 30% initially denied | AMA survey data |
| Americans with rheumatoid arthritis | ~1.5 million | CDC |
| Americans with Crohn's or UC | ~3 million | CDC |
| Americans with psoriasis | ~8 million | NPF |
| US specialty drug spend as % of total Rx | ~55% of drug spend | IQVIA 2025 |
| Biologic delivery temperature requirement | 36°F–46°F (cold chain) | FDA/USP |
HARO & Expert Source Availability
BiologicHealthPlus responds to HARO (Help a Reporter Out), Qwoted, ProfNet, and direct journalist inquiries. Our clinical pharmacists can provide rapid expert commentary on:
- Breaking news about biologic drug approvals, biosimilar launches, and FDA actions
- Healthcare policy changes affecting specialty drug access and prior authorization
- Patient stories and perspectives on biologic therapy costs and access challenges
- Drug pricing legislation and its impact on specialty pharmacy patients
- Autoimmune disease awareness and treatment advances
Response time: typically within 2–4 hours for urgent media requests. We can provide written quotes, phone interviews, or video interviews.
Social Media & Community
RA Patient Communities
r/rheumatoid Community
r/CrohnsDisease Community
Patient Communities
📬 Contact Our Media Team
For interview requests, expert quotes, HARO responses, data requests, or partnership inquiries, contact our team directly: